Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
G
Granules India Ltd
Score 68/100• Decent
Granules India Ltd shows potential for growth but faces challenges in profitability and execution risks.
Company’s Health80/100
Valuation 40/100 · PB 3.694
Technical Momentum
1M 9.872% 6M 24.144% 1Y -0.702%
Confidence100%
Low leverage (D/E)No promoter pledge
#76
View details ➜
F
Fermenta Biotech Ltd
Score 68/100• Decent
Fermenta Biotech Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
Company’s Health78/100
Valuation 60/100 · PB 2.2372
Technical Avoid
1M -16.19% 6M 7.571% 1Y -8.951%
Confidence100%
Low leverage (D/E)No promoter pledge
#77
View details ➜
E
EVOQ Remedies Ltd
Score 68/100• Decent
EVOQ Remedies Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
Company’s Health53/100
Valuation 100/100 · PB 0.2745
Technical Watch
1M 27.407% 6M 48.338% 1Y -36.234%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#78
View details ➜
C
Cipla Ltd
Score 68/100• Decent
Cipla Ltd shows a decent investment profile with consistent growth and profitability, though some risks and governance concerns exist.
Company’s Health82/100
Valuation 40/100 · PB 3.8758
Technical Avoid
1M 2.339% 6M -1.593% 1Y -3.251%
Confidence100%
Low leverage (D/E)No promoter pledge
#79
View details ➜
A
Aster DM Healthcare Ltd
Score 68/100• Decent
Aster DM Healthcare shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health62/100
Valuation 20/100 · PB 9.5988
Technical Momentum
1M 11.804% 6M 32.99% 1Y 52.508%
Confidence100%
Healthy profit marginsDecent revenue growth
Promoter pledge present
#80
View details ➜
P
Phaarmasia Ltd
Score 68/100• Decent
Phaarmasia Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
Company’s Health55/100
Valuation 60/100 · PB 2.63
Technical Avoid
1M -0.119% 6M 11.49% 1Y -28.362%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#81
View details ➜
P
Pfizer Ltd
Score 68/100• Decent
Pfizer Ltd shows decent potential with consistent growth, but faces valuation challenges and execution risks.
Company’s Health84/100
Valuation 20/100 · PB 5.6504
Technical Avoid
1M 1.132% 6M 21.218% 1Y 2.179%
Confidence100%
Low leverage (D/E)No promoter pledge
#82
View details ➜
N
Nectar Lifesciences Ltd
Score 68/100• Decent
Nectar Lifesciences Ltd shows potential in a growing sector, but faces challenges in consistency and valuation, warranting cautious observation.
Company’s Health27/100
Valuation 100/100 · PB 0.3638
Technical Avoid
1M 11.623% 6M -28.918% 1Y -58.859%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#83
View details ➜
M
Max India Ltd
Score 68/100• Decent
Max India Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
Company’s Health45/100
Valuation 40/100 · PB 3.1287
Technical Avoid
1M 0.562% 6M 14.878% 1Y -16.066%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#84
View details ➜
M
Makers Laboratories Ltd
Score 68/100• Decent
Makers Laboratories Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
Company’s Health64/100
Valuation 100/100 · PB 0.6241
Technical Avoid
1M -3.731% 6M -13.612% 1Y -21.107%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#85
View details ➜
L
Lotus Eye Hospital and Institute Ltd
Score 68/100• Decent
The stock shows potential but faces challenges in growth consistency and profitability metrics.
Company’s Health55/100
Valuation 40/100 · PB 4.3336
Technical Avoid
1M 2.293% 6M 53.43% 1Y 79.357%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#86
View details ➜
L
Laurus Labs Ltd
Score 68/100• Decent
Laurus Labs Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics.
Company’s Health68/100
Valuation 20/100 · PB 11.1853
Technical Momentum
1M 13.831% 6M 53.678% 1Y 94.127%
Confidence100%
Weak ROEPromoter pledge present
#87
View details ➜
K
KMC Speciality Hospitals (India) Ltd
Score 68/100• Decent
KMC Speciality Hospitals shows potential in a growing sector, but faces challenges in execution and profitability consistency.
Company’s Health94/100
Valuation 20/100 · PB 6.8408
Technical Avoid
1M 4.948% 6M -1.062% 1Y -14.828%
Confidence100%
No promoter pledgeDecent revenue growth
#88
View details ➜
J
Jupiter Life Line Hospitals Ltd
Score 68/100• Decent
Jupiter Life Line Hospitals Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health83/100
Valuation 20/100 · PB 7.6784
Technical Avoid
1M 4.098% 6M 8.907% 1Y 18.116%
Confidence100%
Low leverage (D/E)No promoter pledge
#89
View details ➜
J
Jubilant Pharmova Ltd
Score 68/100• Decent
Jubilant Pharmova Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
Company’s Health54/100
Valuation 60/100 · PB 2.7932
Technical Avoid
1M 3.594% 6M 21.396% 1Y -9.14%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#90
View details ➜
Showing 76 to 90 of 301 (21 Pages)